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Background: The National Screening Program for colorectal cancer is scheduled to commence in the near future.
Previous studies on the topic of colorectal cancer and screening have highlighted paucity in public awareness of
epidemiology, symptoms and signs of colorectal cancer. The aim of this study was to assess understanding of
colorectal cancer and screening in a representative sample of the local catchment population of Mayo General
Hospital.
Methods: A prospective cohort study was instituted utilising an anonymous survey, which was distributed at
consecutive general surgical out-patient clinics over a one month period prior to initiation of the screening
program. Data collected included demographics, presenting complaint type and duration, and general knowledge
of colorectal cancer facts. Attitudes towards screening were also evaluated.
Results: Eighty-eight of the one hundred and thirty six patients sampled were female (65%). Thirty-six per cent of
the sample was within the screening target age-group (55–74), with mean age 53years (+/−18). Most respondents
recognised bleeding per rectum as a possible symptom of colorectal cancer. A significant proportion, however,
incorrectly selected less sinister symptoms as concerning, while only fifty per cent correctly cited weight loss. Family
history was acknowledged as a risk factor by fifty-seven per cent with age and gender cited less often (29%, 4%),
while forty-seven per cent incorrectly cited stress as a risk. Screening was defined as testing of symptomatic
patients or those with a positive family history by eighty-one per cent of respondents, with only nineteen per cent
associating screening with an asymptomatic cohort. Strikingly, twenty-five per cent of patients would decline
screening.
Conclusions: There remains poverty of awareness regarding colorectal cancer. More public health initiatives are
required to help improve understanding of the disease process, and to improve public compliance with the
screening initiative.
Keywords: Colorectal cancer, Screening, ColonoscopyBackground
Colorectal cancer in Ireland remains a significant health
problem despite advances in treatment protocols. In
2011, 2270 newly diagnosed cases were documented,
accounting for 12.9% of invasive cancers in the Irish
population [1]. There were 910 colorectal cancer-related
deaths in 2011, representing 11.1% of all cancer mortal-
ities [1]. Compared to other European countries, both
colorectal cancer incidence and mortality in Ireland were* Correspondence: terri.mcveigh@gmail.com
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fore that colorectal cancer is an important health prob-
lem in Ireland. As a result of centralisation of cancer
services, Ireland now has high-quality specialist centres
offering multimodal treatments for this disease. Colorec-
tal cancer is also one of the most intensively researched
and well-understood pathologies, with a defined natural
history. For this reason, colorectal cancer fulfils many of
the disease-related WHO criteria for suitability of screen-
ing [2] but acceptability and suitability of screening tests
remain to be determined.al Ltd. This is an Open Access article distributed under the terms of the Creative
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plans to implement a national population-based colo-
rectal cancer screening programme on a phased basis,
starting with the population aged 60–69, with plans to
include, in time, all patients aged 55-74 [3]. As part of
this screening programme, willing participants aged 60–
69 will be sent a screening Faecal Immunochemical Test
kit every two years. An abnormal test will require an
additional screening test in the form of a colonoscopy.
For this phase of the screening programme, the National
Cancer Screening Service has selected fifteen candidate
screening colonoscopy units to undertake provision of
screening colonoscopies. Mayo General Hospital, a sec-
ondary unit in the North-West of Ireland has been se-
lected as one of these screening centres. This centre has
339 beds, and serves a predominantly rural-based popu-
lation of 117000.
Previous work in our centre has highlighted a paucity
of awareness of colorectal cancer symptoms in those
patients presenting on an emergent basis with colorectal
cancer [4]. Harewood et al. more recently published
findings of similar lack of knowledge of this disease
among a cohort attending a gastroenterology clinic in
an urban-based teaching hospital [5]. This review also
illustrated a suboptimal willingness of asymptomatic pa-
tients to undergo colonoscopy as a means of screening
for colorectal cancer.
The aim of this study was to ascertain the understand-
ing of colorectal cancer symptoms and perception of
screening in a representative sample of patients served
by the surgical department of Mayo General Hospital,
and to examine the potential enthusiasm of this cohort
to undergo colonoscopy as part of a screening program.
Methods
Survey
A qualitative prospective anonymous survey-based co-
hort study was undertaken.
The survey was adapted from that utilised by Harewood
et al. [5], and sought information regarding:
 Patient demographics
 Reason for clinic attendance (i.e. colorectal
symptomatology or other)
 Awareness of cancer statistics – causes of cancer
death in Ireland, lifetime colorectal cancer risk
 Awareness of colorectal cancer risk factors and
symptoms
 Understanding of the concept of screening
 Acceptability of colonoscopy as a screening tool
 Knowledge of Faecal Occult Blood Testing (FOBT)
 Impact of time off work and loss of earnings as a
deterring factor to screening compliance
 Factors deterring patients from colonoscopyThe survey was distributed to a cohort of patients
attending a general surgical outpatient clinic in Mayo
General Hospital over a one-month period. Written in-
formation was provided along with the survey facilitating
informed consent, which was garnered by means of tick-
ing a box on the first page of the survey. All data was
collected anonymously.
Ethical considerations
Ethical Approval was sought from and granted by the
Mayo General Hospital Research Ethics Committee fol-
lowing Chairperson’s review.
Statistical analysis
Statistical analyses were performed on the data utilising
PASW (version 18) software. Continuous data was assessed
for normality of distribution using Shapiro-Wilk test [6],
and parametric and non-parametric tests selected as
appropriate.
Results
Demographics and presentation
The total number of surveys returned was one hundred
and thirty-six, with females representing sixty-five per
cent of respondents. The median age of participants was
fifty-two years (range 18–87), which is significantly
younger than the cohort targeted by the new screening
programme. In our study group, twenty-one per cent
(n = 28) of patients fit into the target age group of 60–
69 years. Overall however, thirty-six per cent (n = 49) of
patients were aged 55–74 years, the ultimate target co-
hort of the proposed screening regime (Table 1).
Forty patients were attending the surgical clinic with
symptoms unrelated to colorectal disease. The remaining
ninety-six patients had symptoms ranging from weight
loss to long-standing flatulence. The most common
presenting complaints were bloating and flatulence,
followed by changes in bowel habit (constipation/
diarrhoea). There were significant differences in the pat-
terns of presenting complaints between male and female
patients, with females more likely to present with weight
loss (p = 0.04, x2), and men more likely to present with
bleeding per rectum (p = 0.012, x2).
There were no significant differences in age of patients
with suspicious symptoms compared to those without.
Patients presenting with problems unrelated to colorec-
tal disease were younger than patients presenting with
lower gastrointestinal pathology, but this difference was
not statistically significant.
The majority of patients presented relatively acutely,
with symptoms persisting less than six months (21%).
Males (25%) were more likely than females (19%) to
present earlier; females were more likely to allow
Table 1 Patient demographics and presenting complaint
Gender N (%)
Male 48 (35.29)
Female 88 (64.71)
Age (years)
<30 17 (12.5)
31-54 55 (40.4)
55-59 8 (5.9)
60-69 28 (20.6)
70-74 13 (9.6)
>74 10 (7.4)
Not disclosed 5
Male Female Overall
Mean +/- Std 54.15 +/- 16.42 51.01 +/- 17.48 52.11 +/- 17.11
Median (Range) 53 (20-79) 52 (18-87) 52 (18-87)
Presenting complaints
Male Female P-value (x2)
Blood in bowel
motion
9 (18.75) 6 (6.82) 0.012
Bright red blood
per rectum
11 (22.92) 17 (19.32) 0.341
Bloating 14 (29.17) 38 (43.18) 0.215
Flatulence 14 (29.17) 29 (32.95) 0.954
Diarrhoea 12 (25) 22 (25) 0.634
Constipation 7 (14.58) 26 (29.55) 0.091
Weight loss 0 (0) 8 (9.09) 0.041
Other colorectal
pathology
1 (2.08) 0 (0) 0.145
Non colorectal
related
17 (35.42) 23 (26.14) 0.257
Duration of colorectal symptoms
Male n(%) Female n(%) Total n(%)
<6months 12 (25) 17 (19.32) 29 (21.32)
6months – 1year 3 (6.25) 14 (15.91) 17 (12.5)
1-2years 6 (12.5) 6 (6.82) 12 (8.82)
2-5years 3 (6.25) 14 (15.91) 17 (12.5)
5-10years 3 (6.25) 7 (7.95) 10 (7.35)
Missing 12 (25) 17 (19.32) 11
NA 3 (6.25) 14 (15.91) 40
Table 2 Patient knowledge of epidemiology, risk factors
and symptoms of colorectal cancer
Overall Target group for screening
(aged 55-75years; n = 49)
Lifetime risk of colorectal cancer
Risk N(%)
1 in 5 17 (13) 5 (10)
1 in 10 25 (18) 8 (16)
1 in 15 14 (10) 6 (12)
1 in 100 42 (31) 14 (29)
1 in 1000 13 (10) 2 (4)
Missing 25 (18) 14 (29)
Risk factors for colorectal cancer
Factor N(%)
Age 40 (29) 10 (20)
Gender 6 (4) 0 (0)
Smoking 54 (40) 17 (35)
Stress 64 (47) 21 (43)
Family History 77 (57) 28 (57)
Alcohol 40 (29) 9 (18)
Symptoms concerning for colorectal cancer
Symptom N(%) Association between having
symptom and associating it
with colorectal cancer (x2)
Blood in bowel motion 84 (62) 31 (63) 0.868
BRBPR 61 (45) 20 (41) 0.301
Bloating 15 (11) 4 (8) 0.165
Flatulence 9 (7) 3 (6) 0.299
Diarrhoea 32 (24) 10 (20) 0.232
Constipation 23 (17) 7 (14) 0.182
Weight Loss 68 (50) 22 (45) 0.649
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male counterparts (25%).
Epidemiology of colorectal cancer
When patients were asked to pick the most common cause
of cancer-related death in Ireland (the options to them
given were lung, prostate, ovary, colon and breast), the
most commonly selected answer was breast cancer (n = 50;37%). Thirty-nine (29%) patients correctly recognised lung
cancer as the most common cause of cancer death in
Ireland, while thirty (22%) respondents selected colon
cancer (Table 2).
Respondents were also asked to estimate the lifetime
risk of acquisition of colorectal cancer. The majority of
people incorrectly selected “1in100” (n = 42, 31%). Seven-
teen patients (13%) judged their risk to be as high as 20%.
Fourteen (10%) correctly selected a risk of “1 in 15”.
In questions relating to respondents’ knowledge of
colorectal cancer risk factors: six patients selected gen-
der (4%). However, only forty (29%) patients correctly
acknowledged age as bearing a risk, while patients more
often selected factors such as stress (n = 64; 47%), alcohol
consumption (n = 40; 29%) and smoking (n = 54; 40%)).
The majority of people were aware of the contributory sig-
nificance of family history (n = 77; 57%).
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In questions relating to respondents’ understanding/
knowledge of colorectal cancer symptoms: eighty-four
(62%) of patients correctly identified blood in the bowel
motion as a worrying symptom, and sixty-one (45%)
would be concerned about bright red bleeding per rec-
tum. Nine patients (7%) incorrectly believed flatulence
to be a symptom of colonic cancer. Only sixty-eight
patients (50%) were concerned about weight loss and
only fifty-five (40%) about altered bowel habit. There
was no relationship between having a suspicious symp-
tom (weight loss, altered bowel habit or bleeding per
rectum) and the patients’ association of that symptom
with cancer.
Colonoscopy
When asked to estimate the false negative rate of
colonoscopy the majority of respondents believed the in-
cidence of false negative colonoscopy to be either 0-1%
(n = 41; 30%), or 1-5% (n = 41; 30%). Eight (6%) patients
believed the risk to be as high as 10-20%.
When asked to define what they felt to be an appropri-
ate interval for re-screening in the case of a normal col-
onoscopy. Thirty-two per cent (n = 43) stated “1 year”,
with a further twenty-five (18%) choosing “2 years”.
Worryingly, ten (7%) patients would be reassured by a
normal colonoscopy and would not represent for screen-
ing, while ninety-eight per cent of respondents reported
that they would represent to their GP (n = 99, 73%) or
the Emergency Department (n = 34, 25%) if experiencing
on-going symptoms following a negative colonoscopy
(Table 3).
Screening
Twenty-six (19%) patients correctly recognised “screen-
ing” as testing of an asymptomatic population, while the
remainder associated the term with testing people with
a positive family history (n = 56, 41%), or patients with
symptoms (n = 54, 40%). There was a significant correl-
ation between patients citing family history as a riskTable 3 Factors deterring patients from Colonoscopy
Overall Target Group for screening
Factor N(%)
Fasting 4(3) 1 (2)
Time Off Work 3 (2) 1 (2)
Bowel preparation 45 (33) 17 (35)
Sedation 7 (5) 2 (4)
Perforation 28(21) 11 (22)
Discomfort 34 (25) 6 (12)
Embarrassment 27(20) 7 (14)factor of colorectal disease and those patients selecting
patients with a positive family history as the screening
cohort (p = 0.002, X2).
When asked whether they would undergo screening as
an asymptomatic patient in order to pick up early can-
cer, one hundred and two patients (75%) would comply
with the screening test. Thirty-four patients would not
consent to a colonoscopy in the absence of symptoms.
Interestingly, only forty-seven patients (35%) were aware
of FOBT, with only nine (7%) having been offered this
service by their family practitioner.
Patients were then asked to define what factors they felt
to be most off-putting about a colonoscopy. Twenty-eight
(21%) patients were understandably concerned about the
risk of perforation. Larger proportions were discouraged,
however, by fear of discomfort (n = 34, 25%) or embarrass-
ment (n = 27, 20%). Time off work was also found to be a
significant deterrent. The majority of patients were willing
to miss a morning (n = 23; 17%) or single day (n = 49;
36%), while 3 (2%) patients felt it completely unacceptable
to take time off. Thirteen (10%) people however, were will-
ing to take up to 3 days off.Responses in the target screening population
Forty-nine respondents of all those surveyed were aged
between 55 and 74 years of age, and represent therefore
those patients soon to be targeted for screening, includ-
ing 32 (65%) females and 17 (35%) male patients. Thirty-
two patients attended the clinic with symptoms of
colorectal pathology, with the remaining patients attend-
ing for another unrelated surgical complaint. Of the
symptomatic patients in this age group the most com-
monly cited symptoms included flatulence (n = 16; 50%);
bloating (n = 14; 44%) and changing bowel habit (n = 15;
47%). Nine patients (28%) presented with isolated bleeding
per rectum and two (6%) further patients complained of
unexplained weight loss. Twenty-one patients had symp-
toms on-going for longer than one year (66%).
When asked to identify symptoms worrying for colo-
rectal cancer, compared to asymptomatic patients, symp-
tomatic patients were more likely to be suspicious of
symptoms such as bleeding per rectum (44% -v- 24%);
blood in stool (66% -v- 53%); diarrhoea (19% -v- 18%),
constipation (22% -v- 0%) and weight loss (44% -v- 35%).
Symptomatic patients were also more inclined to be
worried about less sinister symptoms such as bloating
(13% -v- 0%) and flatulence (9% -v- 0%) compared to
asymptomatic controls. Overall, the proportion of this co-
hort quoting individual symptoms as worrying did not de-
viate greatly from the overall sample (Table 2). Of this
cohort in particular, ten patients (20%) considered increas-
ing age to be an associated risk factor for the development
of colorectal cancer.
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FOBT, and four (8%) of these had been made aware of
its availability by their General Practitioner (GP).
Eight (16%) of these patients correctly defined screen-
ing, while 22 (45%) believed its practice to apply only to
patients with a positive family history. 26 patients (53%)
of this particular cohort would accept screening in the
absence of symptoms.
Barriers to uptake of colonoscopic screening
Patients were asked to select which factors would nega-
tively impact on their compliance with colonoscopic in-
vestigations. The most commonly cited factors overall
were the need for bowel preparation (n = 45 (33%)), and
discomfort (n = 34, 25%). Specifically in target group for
screening however, discomfort (n = 6 (12%)) was less
often cited than the risk of perforation (n = 11 (22%)),
and again the need for bowel preparation was the most
commonly quoted dissuasive factor (n = 17 (35%)). In pa-
tients outside of the target screening age group (median
age = 45 years), the risk of discomfort was mentioned as
an off-putting factor as often as the need for bowel prep-
aration (n = 28 (34%)), followed by the risk of embarrass-
ment (n = 20, 24%). The risk of perforation (n = 17, 21%)
was the fourth most commonly cited factor in this par-
ticular cohort.
Discussion
It is well recognised that lack of cancer awareness in the
community can have deleterious effects on time to pres-
entation and, unsurprisingly therefore, on overall sur-
vival [7-10].
There remains a real lack of understanding among the
Irish patient population regarding colorectal disease.
This is particularly concerning considering that this
cohort of patients, taken from outpatient attendees,
represents patients with positive health-seeking behav-
iour. The symptomatic patients in this sample were
concerned enough about their symptoms to attend a
clinic for surgical review, and yet in many cases did not
make any association between lower gastrointestinal
symptomatology and potential malignancy. Further-
more, a significant proportion of patients allowed symp-
toms to persist beyond one year before attending for
investigation. Colorectal cancer in particular remains a
topic of confusion in the community, with large scale
population surveys having recorded especially poor
awareness of colorectal cancer risk factors among the
general public, as well as a reluctance to discuss lower
gastrointestinal symptoms or undergo colorectal screen-
ing [5,11-18].
It is interesting to note that, in line with other studies
[5], our cohort demonstrated a particular concern for
Breast cancer as a cause of cancer death. The highlysuccessful “Pink Ribbon” campaign and the introduction
of “Breast Cancer Awareness Month” annually every
October has led to dramatic increase in motivation for
patients to attend for screening, and have therefore
resulted in an increased rate of detection of breast can-
cers [5]. This represents how powerful public health ini-
tiatives can be in influencing health-seeking behaviour.
It reflects also an inherent willingness of patients to
comply with screening. This compliance has been exem-
plified previously in an Irish Cohort [19]. This type of
strategy has been applied to other pathologies including
oesophageal cancer (Lollipop Day) and Lung Cancer
(November as Lung Cancer Awareness month), and is
imminently applicable to colorectal disease also.
This study highlights a particularly interesting finding.
A significant proportion of patients presented to the
outpatient clinic with symptoms suggestive of colorectal
pathology. There was still a failure in these patients
however to recognise these symptoms as concerning for
colorectal cancer. Comparing symptomatic and asymp-
tomatic patients, symptomatic patients were more likely
to believe colorectal symptoms quoted to be sinister,
although this was not statistically significant. Even in
the symptomatic patient however, worrying symptoms
such as bleeding per rectum and weight loss were
underestimated in their significance. This reflects a pov-
erty of awareness of colorectal cancer symptoms, as well
as underestimation of the risk of colorectal cancer in
the general community. Indeed, forty per cent of patients
underestimated their risk when directly questioned on this
point, with a further eighteen per cent failing to select an
answer.
Patients also displayed no clear understanding of risk
factors for colorectal cancer, which may deter asymp-
tomatic patients from attending for screening. There
was a poverty of recognition of increasing age as a risk
factor, especially in the age group most likely to be
targeted for screening (10(20%) –v- 28(34%)). Fifty-
seven per cent of patients acknowledged the contribu-
tion of family history in the risk of this disease. Our
results compare favourably to those of Harewood et al
[5] in 2009, where only thirty-one per cent of respon-
dents were aware of the influence of family history
and only nine per cent of the impact of increasing age
on risk. This may reflect increased knowledge as result
of enhanced public education initiatives over the last
four years in advance of the formal introduction of
screening. Further efforts are needed however to en-
hance improvements in the public understanding of
this disease.
It is clearly obvious that not only is knowledge of colo-
rectal cancer in the community poor, but opportunistic
intervention and education by GPs is limited. Of the
forty-nine patients of our sample fulfilling the age
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information regarding screening or FOBT from their GP.
Previous studies have identified paucity of knowledge
of colorectal cancers even in the symptomatic cohort
[4]. Increased efforts are needed to educate patient
awareness therefore, to increase compliance with the
screening program, but also to encourage symptomatic
patients to present at an earlier, and more salvageable,
stage of disease.
In the current unease of the Irish economic situation,
we were particularly interested to see whether loss of
earnings resulting from time off work would impact on
patients’ compliance with the screening process. The
majority of patients were willing to miss half a day or
one full day (53%, n = 72), with stepwise decreases in
proportions of patients willing to miss any further incre-
ments in loss of working days. This is a particularly
relevant factor in colonoscopic screening, as the process
involves not only the test itself, but also bowel prepar-
ation on the day prior to screening, and a period of re-
covery following sedation. Compared to mammography
or other screening initiatives, it seems arduous and un-
surprisingly dissuasive.
This study clearly exemplifies the deficiencies in public
awareness of colorectal cancer symptoms and risks, and
highlights the need for augmentation of public health
initiatives.
The single-centre nature of this study is a limiting fac-
tor but the findings are in keeping with previously pub-
lished work from other centres. The majority of previous
work in Ireland has focused on urban-dwellers attending
tertiary specialist centres. We believe this study to be
the first in Ireland to examine the attitudes and aware-
ness of a rural based population attending a general
peripheral centre. In rural Ireland, patients are more
dependent on primary care and the paucity of education
offered by GPs to this sample is concerning. It would be
interesting to repeat the study in a sample from patients
in the community rather than in the health-seeking
population attending for review.
Conclusion
This study clearly demonstrates a lack of public insight
into signs and symptoms of colorectal cancer. The sam-
ple included in this study included a wide variety of ages,
gender and symptom profile, from a predominantly rural
population. It therefore provides a valid representation
of the health-seeking population in the West of Ireland.
An urgent requirement exists for increased Public Health
initiatives to increase knowledge in the community, to en-
courage family practitioners to educate patients and offer
them faecal occult blood testing (FOBT) when indicated,
and to ensure compliance with the screening program
when it is initiated. A particularly interesting and novelfinding in this study is the appearance of loss of time and
earnings as a deterrent in screening participation. This is
particularly valid in the current economic climate, and
should be taken into account in patient education initia-
tives, or indeed in the planning of colonoscopy lists.
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